Questions | Responders to the Question | Answer options | Responders | |
---|---|---|---|---|
The source of blood products? | 250 | Blood bank in your facility | 235 (94.0) | |
Blood bank from another facility | 15 (6.0) | |||
Feasibility of obtaining blood donation from specific groups (e.g., survivors of MERS-CoV) | 237 | Yes | 130 (54.9) | |
The capability to screen for blood-borne viruses in donated blood (e.g., HIV, hepatitis, etc.)? | 248 | Yes | 240 (96.8) | |
Ability to send suspected MERS-CoV samples to a reference laboratory for diagnosis? | 226 | Yes | 173 (76.5) | |
Turn-around time | 164 | 1 day | 15 | |
2 days | 24 | |||
3 days | 44 | |||
4 days | 15 | |||
5 days | 24 | |||
6 days | 3 | |||
7 days | 22 | |||
9 days | 1 | |||
10 days | 7 | |||
14 days | 6 | |||
15 days | 1 | |||
21 days | 2 | |||
Methodologies for MERS-CoV testinga | 205 | Real-time PCR | Yes | 135 |
No | 10 | |||
Do not know | 57 | |||
Sequencing | Yes | 22 | ||
No | 21 | |||
Do not know | 110 | |||
Serology | Yes | 51 | ||
No | 21 | |||
Do not know | 88 | |||
Other (please specify) | 8 | |||
Available diagnostic work-up for severe acute respiratory infectiona | 218 | Blood cultures | Yes | 205 |
No | 4 | |||
Do not know | 6 | |||
Urine bacterial antigen testing | Yes | 153 | ||
No | 28 | |||
Do not know | 30 | |||
Viral antigen testing | Yes | 146 | ||
No | 36 | |||
Do not know | 28 | |||
PCR for bacterial and viral testing | Yes | 170 |